By The United Office on Drugs and Crime

  In the Sahel countries and their neighbours, the high prevalence of infectious diseases, including malaria, coupled with challenges in terms of the availability and affordability of and access to healthcare, creates an environment in which the demand for medical products and services is not fully met through formal channels. The disparity between the demand for and supply of regulated pharmaceutical products leaves room for trafficking, provides an incentive for the involvement of organized criminal groups and fuels the ongoing threat to public safety and public health in the Sahel countries. Between January 2017 and December 2021, at least 605 tons of different medical products were seized in West Africa during international operations.  While there are no reliable estimates of the overall quantities of medical products that are trafficked in different ways and forms in the Sahel countries, studies point to a percentage of substandard and falsified medicines in the medical market of between 19 and 50 per cent. Some 40 per cent of the substandard and falsified medical products reported in the Sahel countries between 2013 and 2021 was discovered in the regulated supply chain. Just as regulated medical products can be diverted, illicitly manufactured medical products can find their way into authorized pharmaceutical outlets, which shows how much the regulated (legal) and unregulated (illicit) supply chains are interconnected. The Sahel countries rely heavily on imports of medical products because their pharmaceutical industries are still in the early stages of development. Of total pharmaceutical expenditure in sub-Saharan Africa in 2019, imports represented as much as 70 to 90 per cent (roughly 14 billion United States dollars ($)). Medical products diverted from the legal supply chain often originate in the main exporting countries of medical products to the Sahel countries, in particular Belgium and France, and to a lesser extent China and India. Others are manufactured in neighbouring countries, including in North Africa and the Gulf of Guinea. The seaports in the Gulf of Guinea, Conakry (Guinea), Tema (Ghana), Lomé (Togo), Cotonou (Benin) and Apapa (Nigeria) can be identified as major entry points for medical products destined for the Sahel countries. Trafficking by air, using postal shipments or carried out by commercial air passengers, is employed for smuggling smaller quantities of medical products. Once in West Africa, trafficked medical products reach the Sahel countries through smugglers who follow traditional trafficking routes using buses, trucks and private cars. Investigations have revealed the involvement of a wide range of opportunistic actors in trafficking in medical products in the Sahel countries, from employees of pharmaceutical companies, public officials, law enforcement officers and health agency workers to street vendors, all motivated by potential financial gain. Despite terrorist groups and non-state armed groups being commonly associated with trafficking in medical products in the Sahel, most reported cases in the region show that the involvement of such groups is limited and mainly revolves around consuming medical products or levying "taxes" on them in the areas under their control. In sub-Saharan Africa, as many as 267,000 deaths per year are linked to falsified and substandard antimalarial medicines. In addition, up to 169,271 are linked to falsified and substandard antibiotics used to treat severe pneumonia in children.     

Vienna: UNODC, 2022. 28p.

By The United Nations Office on Drugs and Crime

The ratio of registered vehicles to people in the Sahel countries is low and per capita daily gasoline consumption is estimated to be among the lowest in the world. Nevertheless, an average at-pump price of $1 per litre would result in a combined annual total market value of at least 5 billion United States dollars ($) for both legal and illegal fuel in the region. Despite some of them producing oil, the Sahel countries rely on fuel imports from Algeria, Libya and Nigeria, where fuel is heavily subsidized. It appears that the low fuel prices in Algeria, Libya and Nigeria are among the most significant drivers of fuel trafficking in the Sahel. In addition to fuel trafficking, cheap gasoline and diesel also fuel the activities of illegal non-state armed groups, including groups deemed “terrorist” by the international community. Moreover, there are some indications that there may be deeper linkages to other forms of smuggling, such as trafficking in medical products, drugs and firearms. There are four major fuel trafficking flows into the Sahel countries: from Nigeria via Benin to Burkina Faso and Mali; from Nigeria via the Niger to Mali; from Algeria to Mali; and from Libya to the Niger and Chad. A large portion of the market for trafficked fuel in the Sahel countries appears to be informally organized. However, recent investigations have revealed the involvement of structured groups with links to prominent individuals with interests in retail fuel companies, financial institutions and corrupt law enforcement officials. This highlights the importance of the formal trade in laundering smuggled fuel. Companies associated with individuals under United Nations Security Council sanctions are also reported to be involved in fuel smuggling from the Niger to Mali. The introduction of fuel subsidies and licensing policies has led to the emergence of powerful business elites in the Sahel countries with sufficient political influence to protect fuel smuggling activities. Opportunities to earn illegal revenue indirectly from fuel trafficking through bribery and other forms of corruption compromise the level of repression that the Sahel countries can exercise on the illicit fuel trade. Issues with, and gaps in, the rule of law in some areas, owing to a combination of a high level of insecurity and vast, porous borders, constitute a key enabling

factor for fuel trafficking in the Sahel. The lack of state presence in remote areas gives room for the proliferation of criminal activities.

Vienna: UNODC, 2022. 24p.

By The United Nations Office on Drugs and Crime

Sahel countries are some of the largest gold producers in Africa. While gold production data can be unreliable, Burkina Faso, Mali, Mauritania and the Niger are estimated to have produced 228 tons of gold in 2021, worth over 12.6 billion United States dollars ($). The gold sector is a major economic driver in the Sahel countries. Artisanal and small-scale gold mining (ASGM) production is estimated at 108 tons per year in Sahel countries, although official ASGM production data is largely unreliable due to the informal nature of the sector. ASGM provides a livelihood to over 1.8 million people in areas where income-generating activities are limited. The sector is characterized by high levels of informality because it often takes place on unlicensed and undeclared mining sites. Gold mining without licenses is illegal in all Sahel countries, although Member States have taken measures to formalize ASGM. Barriers to accessing mining licences often push communities involved in ASGM into a vicious cycle of illegality. Without protection of the law, they depend on a local economy often controlled by transnational organized crime (TOC) groups to fund their operations and to sell their gold production, with limited opportunities for structural investments. These communities are potentially susceptible to

recruitment by armed groups, including violent extremist groups. Porous borders enable gold to be easily moved within the Sahel countries and smuggled out of the region, including to the United Arab Emirates (UAE).

Vienna: UNODC, 2023. 36p.

By The United Nations Office on Drug and Crime (UNODC)

Cocaine, cannabis resin and pharmaceutical opioids are the internationally trafficked drugs most seized in the Sahel. In terms of quantity, cannabis herb is actually the most commonly seized drug in the Sahel countries, but it seems to be produced locally and trafficked mostly for local consumption. Cannabis is also the principal substance for which people seek treatment in the region. The geographical location of West Africa renders it a natural stopover point for cocaine produced in South America en route to Europe, one of the largest consumer markets for cocaine after North America. In a context of increasing cocaine production in South America and increasing demand for the drug in Europe, flows of cocaine trafficked through West Africa have intensified. The re-emergence of large cocaine seizures since 2019 suggests a surge in large shipments of the drug to the coastal countries of West Africa, with 9.5 tons being seized in Cabo Verde. Although the majority of the cocaine reaching West Africa typically continues northwards towards North Africa and Europe via maritime routes along the African coast, an increasing number of significant cocaine seizures involving Sahel countries has provided evidence of large-scale cocaine trafficking through the region. From an average of 13 kg per year in the period 2015–2020, the quantity of cocaine seized in the Sahel countries increased to 41 kg in 2021 and 1,466 kg in 2022, with the bulk reported by Burkina Faso, Mali and the Niger. Annual estimates were not available for 2023, but at the time of writing over 2.3 tons of cocaine had already been seized in Mauritania in 2023.

Cannabis resin is the second most seized drug in the Sahel countries after cannabis herb, with 24.8 tons seized in the period 2021–2022. Representing over 52.6 per cent of the total quantity of cannabis resin seized in West and Central Africa in the same period, this illustrates the importance of the Sahel route for cannabis resin trafficking. According to data from the Sahel countries, the cannabis resin trafficked in the region generally originates in Morocco, where an increase in cannabis resin production has been reported, reaching an estimated 901 tons in 2022. It is typically destined for countries in Western Europe and North Africa. Aside from the direct trafficking route between Spain and Morocco, cannabis resin is typically trafficked overland from Morocco to Mauritania, Mali, Burkina Faso, the Niger and Chad, then onwards to Algeria, Libya and Egypt. Since 2020, the Sahel countries have reported that cannabis resin is being transported by sea via an alternative maritime route, mostly from Morocco down the coast of West Africa to ports on the Gulf of Guinea, in Benin and Togo in particular, before being transported north to the Niger and then on to North Africa. The reconfiguration of the cannabis resin trafficking routes in West Africa is likely to have an effect on the drug distribution networks operating between North Africa, the Gulf of Guinea and the Sahel. For example, Moroccan drug traffickers are likely to become less reliant on Malian organized crime groups, while traffickers in the Gulf of Guinea are likely to be increasingly exposed to cannabis resin, enabling them to diversify their trade and the markets to which they have access. Between 2011 and 2021, the annual prevalence of opioid use (including opiates) increased from 0.33 to 1.24 per cent in Africa. The non-medical use of pharmaceutical opioids appears to have grown considerably, from just two countries (the Niger and Togo) citing tramadol as the principal drug of concern by people entering drug treatment in 2017, to five countries (Burkina Faso, Liberia, Mali, the Niger and Sierra Leone) in 2019. Indeed, the non-medical use of tramadol remains a threat in North, West and Central Africa in particular. Tramadol is the most used opioid for non-medical purposes in Burkina Faso, Mauritania, the Niger, Nigeria, Senegal, Sierra Leone and Togo. Moreover, in 2022, Tramadol was the second most common drug for which female patients sought treatment in Mali and Mauritania etc.

Vienna: UNODC, 2023. 40p.